At the same time, Stedical Scientific launched a multi-center clinical trial to evaluate the safety and efficacy of PermeaDerm ® in China. The first patient with deep second-degree burns was enrolled, ...
CARLSBAD, CA / ACCESSWIRE / December 29, 2015 / University of Rochester (Dr. Phipps), PermeaDerm, Inc. (Dr. Woodroof) and BioDot Inc. (Dr. Lemmo) are collaborating to make a Temporary Skin Substitute ...
VALENCIA, Calif., Jan. 25, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced ...
AVITA Medical, Inc., a commercial-stage regenerative medicine company, announced it has entered into an exclusive multi-year distribution agreement with Stedical Scientific, Inc. to commercialize ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Avita Medical Ltd is ...
Avita Medical Ltd is conducting a clinical study titled ‘A Prospective Post-Market Multicenter Randomized Controlled Clinical Study to Investigate Clinical Outcomes and Associated Costs When ...
VALENCIA, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (RCEL) (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering a portfolio of transformative ...
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
VALENCIA, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced ...
RECELL analyses show consistent trends in healing, reduced complications, and shorter hospital stays across studies and real-world registry data VALENCIA, Calif., Jan. 25, 2026 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results